Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Monopar Therapeutics (MNPR)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Monopar Therapeutics since year 2005.
Table 2 shows the detailed insider transactions of Monopar Therapeutics since 2005.
The reporting company's ticker symbol is MNPR. The reporting company's CIK number is 1645469.
The total value of stock buying since 2005 is $6,005,104.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $55,317.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-12-18||Tsuchimoto Kim R (Chief Financial Officer)||Buy||325||8.00||2,600|
|2019-12-18||Brown Michael J||Buy||125,000||8.00||1,000,000|
|2019-11-26||Rioux Patrice||Option Ex||18,433||3.00||55,317|
Insider trading activities including stock purchases, stock sales, and option exercises of MNPR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Monopar Therapeutics (symbol MNPR, CIK number 1645469) see the Securities and Exchange Commission (SEC) website.